Dr. Bunnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue
Dana Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-5024Fax+1 617-582-7328- Is this information wrong?
Education & Training
- Massachusetts Institute of TechnologyMBA, Business/Management, 2006 - 2008
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996
- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
- Brigham and Women's HospitalInternship, Internal Medicine, 1990 - 1991
- Harvard School of Public HealthMPH, 1988 - 1990
- Harvard Medical SchoolClass of 1989, MD
Certifications & Licensure
- MA State Medical License 1992 - 2025
- ME State Medical License 2022 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer Start of enrollment: 2004 Jan 01
- Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer Start of enrollment: 2005 Oct 01
- Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Design and Implementation of an Opt-Out, End-to-End, PreemptiveTesting Program for Patients Planned for a Systemic Fluoropyrimidine.Garrett Rompelman, Angela Chen, Samantha Morrison-Ma, Lindsay Murray, Maria Ferzoco, Joseph O Jacobson, Craig Bunnell, Andrew J Wagner, Daniel Roberts, Jennifer Chan, ...> ;JCO Oncology Practice. 2024 Apr 12
- Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for...Dario Trapani, Qingchun Jin, Caroline C Block, Rachel A Freedman, Nancy U Lin, Elizabeth A Mittendorf, Tari A King, Susan C Lester, Jane E Brock, Nabihah Tayob, Craig ...> ;JCO Oncology Practice. 2023 Aug 1
- 1 citationsEarly Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care.David M. Jackman, Emily Foster, Joanna M. Hamilton, Carole Kathleen Tremonti, Craig A. Bunnell, Sherri O. Stuver, Joseph O. Jacobson> ;American Journal of Medical Quality. 2021 Jun 8
- Join now to see all
Press Mentions
- Late Stage Cancer Rates Could Rise if ACA Ruling Stands, Experts WorryMarch 31st, 2023
- Dana-Farber Brigham Cancer Center Opens New Facility in FoxboroughAugust 10th, 2022
- Christ Hospital Becomes Newest Member of Dana-Farber Brigham Cancer Care CollaborativeJuly 6th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: